WANBURY
Quarterly Results Analysis [Dec2023]
WANBURY Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹145 Cr | ₹144 Cr | ₹146 Cr | ₹133 Cr | ₹126 Cr | ₹124 Cr | ₹117 Cr | ₹134 Cr |
Expenses | ₹124 Cr | ₹127 Cr | ₹133 Cr | ₹119 Cr | ₹119 Cr | ₹118 Cr | ₹120 Cr | ₹122 Cr |
Operating Income | ₹21 Cr | ₹17 Cr | ₹13 Cr | ₹14 Cr | ₹6 Cr | ₹6 Cr | ₹-3 Cr | ₹13 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹-2 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr |
Interest | ₹8 Cr | ₹8 Cr | ₹6 Cr | ₹8 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹1 Cr | ₹-3 Cr | ₹-1 Cr | ₹-7 Cr | ₹82 Cr |
Profit After Tax | ₹10 Cr | ₹7 Cr | ₹5 Cr | ₹1 Cr | ₹-3 Cr | ₹-1 Cr | ₹-7 Cr | ₹83 Cr |
EPS | ₹3.14 | ₹2.25 | ₹1.43 | ₹0.31 | ₹-1.00 | ₹-0.27 | ₹-2.22 | ₹25.27 |
Industry Peers & Returns | 1W | 1M | 1Y |
WANBURY | -1.4% | 10.9% | 282.6% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
WANBURY Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.72 % |
Y-o-Y | 15.68 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹145 Cr | 0.72 | |
Sep2023 | ₹144 Cr | -1.25 | |
Jun2023 | ₹146 Cr | 10.01 | |
Mar2023 | ₹133 Cr | 5.72 | |
Dec2022 | ₹126 Cr | 1.47 | |
Sep2022 | ₹124 Cr | 6.00 | |
Jun2022 | ₹117 Cr | -12.99 | |
Mar2022 | ₹134 Cr | - |
WANBURY Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 21.92 % |
Y-o-Y | 227.54 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹21 Cr | 21.92 | |
Sep2023 | ₹17 Cr | 29.94 | |
Jun2023 | ₹13 Cr | -5.75 | |
Mar2023 | ₹14 Cr | 119.38 | |
Dec2022 | ₹6 Cr | 15.37 | |
Sep2022 | ₹6 Cr | Positive | |
Jun2022 | ₹-3 Cr | Negative | |
Mar2022 | ₹13 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 20.98 % |
Y-o-Y | 183.24 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 14.53% | 20.98 | |
Sep2023 | 12.01% | 31.69 | |
Jun2023 | 9.12% | -14.37 | |
Mar2023 | 10.65% | 107.60 | |
Dec2022 | 5.13% | 13.75 | |
Sep2022 | 4.51% | Positive | |
Jun2022 | -2.6% | Negative | |
Mar2022 | 9.53% | - |
WANBURY Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 39.53 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹10 Cr | 39.53 | |
Sep2023 | ₹7 Cr | 57.01 | |
Jun2023 | ₹5 Cr | 361.97 | |
Mar2023 | ₹1 Cr | Positive | |
Dec2022 | ₹-3 Cr | Negative | |
Sep2022 | ₹-1 Cr | Negative | |
Jun2022 | ₹-7 Cr | Negative | |
Mar2022 | ₹83 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 38.43 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 7.06 % | 38.43 | |
Sep2023 | 5.1 % | 58.88 | |
Jun2023 | 3.21 % | 322.37 | |
Mar2023 | 0.76 % | Positive | |
Dec2022 | -2.61 % | Negative | |
Sep2022 | -0.72 % | Negative | |
Jun2022 | -6.2 % | Negative | |
Mar2022 | 61.42 % | - |
WANBURY Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 39.56 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹3.14 | 39.56 | |
Sep2023 | ₹2.25 | 57.34 | |
Jun2023 | ₹1.43 | 361.29 | |
Mar2023 | ₹0.31 | Positive | |
Dec2022 | ₹-1 | Negative | |
Sep2022 | ₹-0.27 | Negative | |
Jun2022 | ₹-2.22 | Negative | |
Mar2022 | ₹25.27 | - |
You may also like the below Video Courses